文献速递肺外科

手术切除对IV期(M1a)非小细胞肺癌孤立性胸膜播散患者的影响:基于队列登记和人群数据库的分析

Effect of Surgical Resection on Isolated Pleural Dissemination in Patients with Stage IV (M1a) Non-Small Cell Lung Cancer: Analysis from a Cohort-Based Registry and a Population-Based Database.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

本研究基于中国西部肺癌数据库(2005-2021)和SEER数据库(2010-2015),比较原发肿瘤切除(PTR)与仅胸膜结节活检对孤立性胸膜播散NSCLC患者的生存影响。WCLC队列289例(PTR 261例,活检28例)和SEER队列2232例(PTR 278例,活检1954例)显示,PTR组5年生存率显著优于活检组(WCLC:28.3% vs 5.0%,P<.0001;SEER:30.5% vs 7.4%,P<.0001)。亚组分析表明,无恶性胸腔积液患者中PTR显著改善生存,且解剖性肺叶切除加系统淋巴结清扫优于部分切除或肺叶切除加淋巴结采样(P=.008)。

要点

  • 孤立性胸膜播散NSCLC患者行原发肿瘤切除与更长生存相关。
  • 无恶性胸腔积液的患者从原发肿瘤切除中获益更显著。
  • 解剖性肺叶切除加系统淋巴结清扫可能优于部分切除或淋巴结采样。

核心结论

  • NSCLC孤立性胸膜播散患者可能代表一个M1a亚组,原发肿瘤切除与更长生存相关,尤其在无恶性胸腔积液时。

研究设计与样本

  • 回顾性队列研究,纳入WCLC数据库(2005-2021)289例和SEER数据库(2010-2015)2232例患者,比较原发肿瘤切除与仅胸膜结节活检的生存差异。

主要发现

  • WCLC队列中PTR组与活检组5年生存率分别为28.3%和5.0%(P<.0001)。
  • SEER队列中PTR组与活检组5年生存率分别为30.5%和7.4%(P<.0001)。
  • 亚组分析显示,无恶性胸腔积液患者中PTR显著改善生存, regardless of tumour size and T stage。
  • 解剖性肺叶切除加系统淋巴结清扫与更好的总生存相关(P=.008)。

临床怎么用

  • 对于孤立性胸膜播散且无恶性胸腔积液的NSCLC患者,可考虑原发肿瘤切除以改善生存。
  • 手术方式宜选择解剖性肺叶切除加系统淋巴结清扫。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Non-small cell lung cancer (NSCLC) with pleural dissemination is categorized as stage IV (M1a) and traditionally deemed a contraindication for surgical intervention. This study aimed to explore the potential role of surgery in NSCLC patients with isolated pleural dissemination. METHODS: Patients who either underwent primary tumour resection (PTR) or received only pleural nodules biopsy were included for analysis from the Western China Lung Cancer (WCLC) database (2005-2021) and Surveillance, Epidemiology, and End Results (SEER) database (2010-2015). Survival curves were generated using the Kaplan-Meier method, with significance assessed by the log-rank test. RESULTS: A total of 289 patients (261 PTR and 28 biopsy only) from the WCLC cohort and 2232 patients (278 PTR and 1954 biopsy only) from the SEER cohort were identified for analysis. In both cohorts, patients who underwent PTR showed significantly better outcomes compared to those who received only pleural nodules biopsy, with the 5-year survival rates of 28.3% versus 5.0% in the WCLC cohort (P < .0001) and 30.5% versus 7.4% in the SEER cohort (P < .0001). Subgroup analysis indicated that PTR significantly improved survival in patients without malignant pleural effusion, regardless of tumour size and T stage. Furthermore, anatomic lobectomy with systematic lymph node dissection was associated with better overall survival than partial resection or lobectomy plus lymph node sampling (P = .008). CONCLUSIONS: NSCLC patients with isolated pleural dissemination may represent an M1a subgroup in whom PTR is associated with longer survival, particularly in the absence of malignant pleural effusion.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Xu Y, Wei S, Yang Z, et al. Effect of Surgical Resection on Isolated Pleural Dissemination in Patients with Stage IV (M1a) Non-Small Cell Lung Cancer: Analysis from a Cohort-Based Registry and a Population-Based Database. Eur J Cardiothorac Surg. 2026. PMID: 41581123. doi:10.1093/ejcts/ezag050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。